UCT-Publikationen I. + II. Quartal 2023

* Mainzer Publikationen (Erst- und / oder Letztautor)
  1. Agrawal-Singh, S, Bagri, J, Giotopoulos, G, Azazi, DMA, Horton, SJ, Lopez, CK, Anand, S, Bach, AS, Stedham, F, Antrobus, R, Houghton, JW, Vassiliou, GS, Sasca, D, Yun, H, Whetton, AD, & Huntly, BJP. (2023). HOXA9 forms a repressive complex with nuclear matrix-associated protein SAFB to maintain acute myeloid leukemia. Blood, 141(14), 1737-1754. doi:10.1182/blood.2022016528 
     
  2. Almansour, H, Schick, F, Nachbar, M, Afat, S, Fritz, V, Thorwarth, D, Zips, D, Bertram, F, Müller, AC, Nikolaou, K, Othman, AE, & Wegener, D. (2023). Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study. Radiol Oncol, 57(2), 184-190. doi:10.2478/raon-2023-0020 
     
  3. *Almstedt, K, Krauthauser, L, Kappenberg, F, Wagner, DC, Heimes, AS, Battista, MJ, Anic, K, Krajnak, S, Lebrecht, A, Schwab, R, Brenner, W, Weikel, W, Rahnenführer, J, Hengstler, JG, Roth, W, Hasenburg, A, Stewen, K, & Schmidt, M. (2023). Discordance of HER2-Low between Primary Tumors and Matched Distant Metastases in Breast Cancer. Cancers (Basel), 15(5). doi:10.3390/cancers15051413 
     
  4. *Altmann, S, Abello Mercado, MA, Ucar, FA, Kronfeld, A, Al-Nawas, B, Mukhopadhyay, A, Booz, C, Brockmann, MA, & Othman, AE. (2023). Ultra-High-Resolution CT of the Head and Neck with Deep Learning Reconstruction-Assessment of Image Quality and Radiation Exposure and Intraindividual Comparison with Normal-Resolution CT. Diagnostics (Basel), 13(9). doi:10.3390/diagnostics13091534 
     
  5. Alwers, E, Kather, JN, Kloor, M, Brobeil, A, Tagscherer, KE, Roth, W, Echle, A, Amitay, EL, Chang-Claude, J, Brenner, H, & Hoffmeister, M. (2023). Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study. J Pathol Clin Res, 9(2), 129-136. doi:10.1002/cjp2.304 
     
  6. Andretto, V, Repellin, M, Pujol, M, Almouazen, E, Sidi-Boumedine, J, Granjon, T, Zhang, H, Remaut, K, Jordheim, LP, Briançon, S, Keil, IS, Vascotto, F, Walzer, KC, Sahin, U, Haas, H, Kryza, D, & Lollo, G. (2023). Hybrid core-shell particles for mRNA systemic delivery. J Control Release, 353, 1037-1049. doi:10.1016/j.jconrel.2022.11.042 
     
  7. *Anic, K, Altehoefer, C, Krajnak, S, Schmidt, MW, Schwab, R, Linz, VC, Schmidt, M, Westphalen, C, Hartmann, EK, Hasenburg, A, & Battista, MJ. (2023). The preoperative G8 geriatric screening tool independently predicts survival in older patients with endometrial cancer: results of a retrospective single-institution cohort study. J Cancer Res Clin Oncol, 149(2), 851-863. doi:10.1007/s00432-022-03934-1 
     
  8. *Anic, K, Flohr, F, Schmidt, MW, Krajnak, S, Schwab, R, Schmidt, M, Westphalen, C, Eichelsbacher, C, Ruckes, C, Brenner, W, Hasenburg, A, & Battista, MJ. (2023). Frailty assessment tools predict perioperative outcome in elderly patients with endometrial cancer better than age or BMI alone: a retrospective observational cohort study. J Cancer Res Clin Oncol, 149(4), 1551-1560. doi:10.1007/s00432-022-04038-6 
     
  9. *Anic, K, Varchola, J, Schmidt, MW, Schwab, R, Linz, VC, Schmidt, M, Hardt, R, Hartmann, EK, Ruckes, C, Hasenburg, A, & Battista, MJ. (2023). Influence of interdisciplinary frailty screening on perioperative complication rates in elderly ovarian cancer patients: results of a retrospective observational study. Arch Gynecol Obstet, 307(6), 1929-1940. doi:10.1007/s00404-022-06850-4 
     
  10. Arndt, V, Doege, D, Fröhling, S, Albers, P, Algül, H, Bargou, R, Bokemeyer, C, Bornhäuser, M, Brandts, CH, Brossart, P, Brucker, SY, Brümmendorf, TH, Döhner, H, Gattermann, N, Hallek, M, Heinemann, V, Keilholz, U, Kindler, T, von Levetzow, C, Lordick, F, Neumann, UP, Peters, C, Schadendorf, D, Stilgenbauer, S, Zander, T, Zips, D, Braun, D, Seufferlein, T, Nettekoven, G, & Baumann, M. (2023). Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic. J Cancer Res Clin Oncol, 149(2), 913-919. doi:10.1007/s00432-022-04407-1 
     
  11. *Blatt, S, Kämmerer, PW, Krüger, M, Surabattula, R, Thiem, DGE, Dillon, ST, Al-Nawas, B, Libermann, TA, & Schuppan, D. (2023). High-Multiplex Aptamer-Based Serum Proteomics to Identify Candidate Serum Biomarkers of Oral Squamous Cell Carcinoma. Cancers (Basel), 15(7). doi:10.3390/cancers15072071 
     
  12. Bodmer, N, Hecker-Nolting, S, Friedel, G, Blattmann, C, Kager, L, Kessler, T, Kevric, M, Kühne, T, Mettmann, V, Müller-Abt, P, Sorg, B, Theobald, M, & Bielack, SS. (2023). Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group. Cancer, 129(12), 1895-1903. doi:10.1002/cncr.34744 
     
  13. *Bogucka-Janczi, K, Harms, G, Coissieux, MM, Bentires-Alj, M, Thiede, B, & Rajalingam, K. (2023). ERK3/MAPK6 dictates CDC42/RAC1 activity and ARP2/3-dependent actin polymerization. Elife, 12. doi:10.7554/eLife.85167 
     
  14. Boonsanay, V, Mosa, MH, Looso, M, Weichenhan, D, Ceteci, F, Pudelko, L, Lechel, A, Michel, CS, Künne, C, Farin, HF, Plass, C, & Greten, FR. (2023). Loss of SUV420H2-Dependent Chromatin Compaction Drives Right-Sided Colon Cancer Progression. Gastroenterology, 164(2), 214-227. doi:10.1053/j.gastro.2022.10.036 
     
  15. Bos-van den Hoek, DW, Tuinman, MA, Hillen, MA, Huijgens, FL, Kurpershoek, E, Calaminus, G, Kaatsch, P, Hagedoorn, M, & Lehmann, V. (2023). Disclosing a history of childhood cancer to romantic partners. Psychooncology, 32(6), 904-912. doi:10.1002/pon.6130 
     
  16. *Bossart, M, Plett, H, Krämer, B, Braicu, E, Czogalla, B, Klar, M, Singer, S, Mayr, D, Staebler, A, du Bois, A, Kommoss, S, Link, T, Burges, A, Heitz, F, Grube, M, Trillsch, F, Harter, P, Wimberger, P, Buderath, P, & Hasenburg, A. (2023). Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database. Arch Gynecol Obstet, 307(4), 1155-1162. doi:10.1007/s00404-022-06781-0 
     
  17. *Bostel, T, Akbaba, S, Wollschläger, D, Mayer, A, Nikolaidou, E, Murnik, M, Kirste, S, Rühle, A, Grosu, AL, Debus, J, Fottner, C, Moehler, M, Grimminger, P, Schmidberger, H, & Nicolay, NH. (2023). Chemoradiotherapy in geriatric patients with squamous cell carcinoma of the esophagus: Multi-center analysis on the value of standard treatment in the elderly. Front Oncol, 13, 1063670. doi:10.3389/fonc.2023.1063670 
     
  18. *Boudissa, M, Porcheron, G, Wagner, D, Traub, F, Farah, G, & Rommens, PM. (2023). Internal fixation of radiation-induced fragility fractures of the pelvis: a case series. Arch Orthop Trauma Surg, 143(2), 865-871. doi:10.1007/s00402-022-04358-9 
     
  19. Brackmann, LK, Foraita, R, Schwarz, H, Poplawski, A, Hankeln, T, Galetzka, D, Zahnreich, S, Spix, C, Blettner, M, Schmidberger, H, & Marron, M. (2023). Self-administered questionnaire assessing childhood cancer treatments and associated risks for adverse health outcomes - The KiKme study. Front Oncol, 13, 1150629. doi:10.3389/fonc.2023.1150629 
     
  20. *Brose, A, Michalski, K, Ruf, J, Tosch, M, Eschmann, SM, Schreckenberger, M, König, J, Nestle, U, & Miederer, M. (2023). PET/CT reading for relapse in non-small cell lung cancer after chemoradiotherapy in the PET-Plan trial cohort. Cancer Imaging, 23(1), 45. doi:10.1186/s40644-023-00567-6 
     
  21. Burgard, C, Hoffmann, MA, Frei, M, Buchholz, HG, Khreish, F, Marlowe, RJ, Schreckenberger, M, Ezziddin, S, & Rosar, F. (2023). Detection Efficacy of (68)Ga-PSMA-11 PET/CT in Biochemical Recurrence of Prostate Cancer with Very Low PSA Levels: A 7-Year, Two-Center "Real-World" Experience. Cancers (Basel), 15(5). doi:10.3390/cancers15051376 
     
  22. *Canales Albendea, M, Canonico, PL, Cartron, G, Deiters, B, Jommi, C, Marks, R, Rioufol, C, Sancho Cia, JM, Santoro, A, & Wagner-Drouet, EM. (2023). Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries. Front Med (Lausanne), 10, 1128295. doi:10.3389/fmed.2023.1128295 
     
  23. *Capovilla, G, Uzun, E, Scarton, A, Moletta, L, Hadzijusufovic, E, Provenzano, L, Salvador, R, Pierobon, ES, Zanchettin, G, Tagkalos, E, Berlth, F, Lang, H, Valmasoni, M, & Grimminger, PP. (2023). Minimally invasive Ivor Lewis esophagectomy in the elderly patient: a multicenter retrospective matched-cohort study. Front Oncol, 13, 1104109. doi:10.3389/fonc.2023.1104109 
     
  24. Cavalieri, S, Vener, C, LeBlanc, M, Lopez-Perez, L, Fico, G, Resteghini, C, Monzani, D, Marton, G, Pravettoni, G, Moreira-Soares, M, Filippidou, DE, Almeida, A, Bilbao, A, Mehanna, H, Singer, S, Thomas, S, Lacerenza, L, Manfuso, A, Copelli, C, Mercalli, F, Frigessi, A, Martinelli, E, & Licitra, L. (2023). A multicenter randomized trial for quality of life evaluation by non-invasive intelligent tools during post-curative treatment follow-up for head and neck cancer: Clinical study protocol. Front Oncol, 13, 1048593. doi:10.3389/fonc.2023.1048593 
     
  25. Chaika, M, Afat, S, Wessling, D, Afat, C, Nickel, D, Kannengiesser, S, Herrmann, J, Almansour, H, Männlin, S, Othman, AE, & Gassenmaier, S. (2023). Deep learning-based super-resolution gradient echo imaging of the pancreas: Improvement of image quality and reduction of acquisition time. Diagn Interv Imaging, 104(2), 53-59. doi:10.1016/j.diii.2022.06.006 
     
  26. *Cichos, S, Schätzlein, E, Wiesmann-Imilowski, N, Blaeser, A, Henrich, D, Frank, J, Drees, P, Gercek, E, & Ritz, U. (2023). A new 3D-printed polylactic acid-bioglass composite for bone tissue engineering induces angiogenesis in vitro and in ovo. Int J Bioprint, 9(5), 751. doi:10.18063/ijb.751 
     
  27. Coelingh Bennink, HJT, Schultz, IJ, Schmidt, M, Jordan, VC, Briggs, P, Egberts, JFM, Gemzell-Danielsson, K, Kiesel, L, Kluivers, K, Krijgh, J, Simoncini, T, Stanczyk, FZ, & Langer, RD. (2023). Progesterone from ovulatory menstrual cycles is an important cause of breast cancer. Breast Cancer Res, 25(1), 60. doi:10.1186/s13058-023-01661-0 
     
  28. Cotarelo, CL, Schad, A, Schmidt, M, Hönig, A, Sleeman, JP, & Thaler, S. (2023). Detection of Cellular Senescence Reveals the Existence of Senescent Tumor Cells within Invasive Breast Carcinomas and Related Metastases. Cancers (Basel), 15(6). doi:10.3390/cancers15061860 
     
  29. Craddock, M, Nestle, U, Koenig, J, Schimek-Jasch, T, Kremp, S, Lenz, S, Banfill, K, Davey, A, Price, G, Salem, A, Faivre-Finn, C, van Herk, M, & McWilliam, A. (2023). Cardiac Function Modifies the Impact of Heart Base Dose on Survival: A Voxel-Wise Analysis of Patients With Lung Cancer From the PET-Plan Trial. J Thorac Oncol, 18(1), 57-66. doi:10.1016/j.jtho.2022.09.004 
     
  30. *Damirov, F, Büsing, K, Yavuz, G, Hatz, R, Manapov, F, Michels, J, Hohenberger, P, & Roessner, E. (2023). Preoperative Hilar and Mediastinal Lymph Node Staging in Patients with Suspected or Diagnosed Lung Cancer: Accuracy of 18F-FDG-PET/CT:A Retrospective Cohort Study of 138 Patients. Diagnostics (Basel), 13(3). doi:10.3390/diagnostics13030403 
     
  31. *Damirov, F, Stoleriu, MG, Manapov, F, Büsing, K, Michels, JD, Preissler, G, Hatz, RA, Hohenberger, P, & Roessner, ED. (2023). Histology of the Primary Tumor Correlates with False Positivity of Integrated 18F-FDG-PET/CT Lymph Node Staging in Resectable Lung Cancer Patients. Diagnostics (Basel), 13(11). doi:10.3390/diagnostics13111893 
     
  32. Dayan, D, Leinert, E, Singer, S, Janni, W, Kühn, T, Flock, F, Felberbaum, R, Herbert, SL, Wöckel, A, & Schwentner, L. (2023). Association of social service counseling in breast cancer patients with financial problems, role functioning and employment-results from the prospective multicenter BRENDA II study. Arch Gynecol Obstet, 307(2), 541-547. doi:10.1007/s00404-022-06604-2 
     
  33. de Baat, EC, Feijen, EAM, Reulen, RC, Allodji, RS, Bagnasco, F, Bardi, E, Belle, FN, Byrne, J, van Dalen, EC, Debiche, G, Diallo, I, Grabow, D, Hjorth, L, Jankovic, M, Kuehni, CE, Levitt, G, Llanas, D, Loonen, J, Zaletel, LZ, Maule, MM, Miligi, L, van der Pal, HJH, Ronckers, CM, Sacerdote, C, Skinner, R, Jakab, Z, Veres, C, Haddy, N, Winter, DL, de Vathaire, F, Hawkins, MM, & Kremer, LCM. (2023). Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study. J Clin Oncol, 41(1), 96-106. doi:10.1200/jco.21.02944 
     
  34. De Lorenzi, F, Rizzo, LY, Daware, R, Motta, A, Baues, M, Bartneck, M, Vogt, M, van Zandvoort, M, Kaps, L, Hu, Q, Thewissen, M, Casettari, L, Rijcken, CJF, Kiessling, F, Sofias, AM, & Lammers, T. (2023). Profiling target engagement and cellular uptake of cRGD-decorated clinical-stage core-crosslinked polymeric micelles. Drug Deliv Transl Res, 13(5), 1195-1211. doi:10.1007/s13346-022-01204-8 
     
  35. *Degenhardt, T, Fasching, PA, Lüftner, D, Müller, V, Thomssen, C, Schem, C, Witzel, I, Decker, T, Tesch, H, Kümmel, S, Uleer, C, Wuerstlein, R, Hoffmann, O, Warm, M, Marschner, N, Schinköthe, T, Kates, RE, Schumacher, J, Otremba, B, Zaiss, M, Harbeck, N, & Schmidt, M. (2023). PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant. Trials, 24(1), 338. doi:10.1186/s13063-023-07306-z 
     
  36. Dominguez-Valentin, M, Haupt, S, Seppälä, TT, Sampson, JR, Sunde, L, Bernstein, I, Jenkins, MA, Engel, C, Aretz, S, Nielsen, M, Capella, G, Balaguer, F, Evans, DG, Burn, J, Holinski-Feder, E, Bertario, L, Bonanni, B, Lindblom, A, Levi, Z, Macrae, F, Winship, I, Plazzer, JP, Sijmons, R, Laghi, L, Della Valle, A, Heinimann, K, Dębniak, T, Fruscio, R, Lopez-Koestner, F, Alvarez-Valenzuela, K, Katz, LH, Laish, I, Vainer, E, Vaccaro, C, Carraro, DM, Monahan, K, Half, E, Stakelum, A, Winter, D, Kennelly, R, Gluck, N, Sheth, H, Abu-Freha, N, Greenblatt, M, Rossi, BM, Bohorquez, M, Cavestro, GM, Lino-Silva, LS, Horisberger, K, Tibiletti, MG, Nascimento, ID, Thomas, H, Rossi, NT, Apolinário da Silva, L, Zaránd, A, Ruiz-Bañobre, J, Heuveline, V, Mecklin, JP, Pylvänäinen, K, Renkonen-Sinisalo, L, Lepistö, A, Peltomäki, P, Therkildsen, C, Madsen, MG, Burgdorf, SK, Hopper, JL, Win, AK, Haile, RW, Lindor, N, Gallinger, S, Le Marchand, L, Newcomb, PA, Figueiredo, J, Buchanan, DD, Thibodeau, SN, von Knebel Doeberitz, M, Loeffler, M, Rahner, N, Schröck, E, Steinke-Lange, V, Schmiegel, W, Vangala, D, Perne, C, Hüneburg, R, Redler, S, Büttner, R, Weitz, J, Pineda, M, Duenas, N, Vidal, JB, Moreira, L, Sánchez, A, Hovig, E, Nakken, S, Green, K, Lalloo, F, Hill, J, Crosbie, E, Mints, M, Goldberg, Y, Tjandra, D, Ten Broeke, SW, Kariv, R, Rosner, G, Advani, SH, Thomas, L, Shah, P, Shah, M, Neffa, F, Esperon, P, Pavicic, W, Torrezan, GT, Bassaneze, T, Martin, CA, Moslein, G, & Moller, P. (2023). Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database. EClinicalMedicine, 58, 101909. doi:10.1016/j.eclinm.2023.101909 
     
  37. Dudley, IM, Sunguc, C, Heymer, EJ, Winter, DL, Teepen, JC, Belle, FN, Bárdi, E, Bagnasco, F, Gudmundsdottir, T, Skinner, R, Michel, G, Byrne, J, Øfstaas, H, Jankovic, M, Mazić, M, Mader, L, Loonen, J, Garwicz, S, Wiebe, T, Alessi, D, Allodji, RS, Haddy, N, Grabow, D, Kaatsch, P, Kaiser, M, Maule, MM, Jakab, Z, Gunnes, MW, Terenziani, M, Zaletel, LZ, Kuehni, CE, Haupt, R, de Vathaire, F, Kremer, LC, Lähteenmäki, PM, Winther, JF, Hjorth, L, Hawkins, MM, & Reulen, RC. (2023). Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study. Cancer, 129(3), 426-440. doi:10.1002/cncr.34561 
     
  38. Dummer, R, Flaherty, KT, Robert, C, Arance, A, JW, BdG, Garbe, C, Gogas, HJ, Gutzmer, R, Krajsová, I, Liszkay, G, Loquai, C, Mandalà, M, Schadendorf, D, Yamazaki, N, Pietro, AD, Cantey-Kiser, J, Edwards, M, & Ascierto, PA. (2023). COLUMBUS 5-year update: a randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF. Future Oncol, 19(16), 1091-1098. doi:10.2217/fon-2022-1258 
     
  39. *Duwe, G, Boehm, K, Haack, M, Sparwasser, P, Brandt, MP, Mager, R, Tsaur, I, Haferkamp, A, & Höfner, T. (2023). Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected. World J Urol, 41(5), 1293-1299. doi:10.1007/s00345-023-04352-9 
     
  40. *Duwe, G, Fischer, ND, Haack, M, Höfner, T, Haferkamp, A, & Brandt, MP. (2023). Solitary cardiac metastasis of urothelial carcinoma of the urinary bladder with squamous cell differentiation - a rare manifestation. Urol Case Rep, 46, 102318. doi:10.1016/j.eucr.2023.102318 
     
  41. *El Malki, K, Wehling, P, Alt, F, Sandhoff, R, Zahnreich, S, Ustjanzew, A, Wilzius, C, Brockmann, MA, Wingerter, A, Russo, A, Beck, O, Sommer, C, Ottenhausen, M, Frauenknecht, KBM, Paret, C, & Faber, J. (2023). Glucosylceramide Synthase Inhibitors Induce Ceramide Accumulation and Sensitize H3K27 Mutant Diffuse Midline Glioma to Irradiation. Int J Mol Sci, 24(12). doi:10.3390/ijms24129905
     
  42. *Elbadawi, M, Boulos, JC, Dawood, M, Zhou, M, Gul, W, ElSohly, MA, Klauck, SM, & Efferth, T. (2023). The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells. Pharmaceutics, 15(4). doi:10.3390/pharmaceutics15041107 
     
  43. *Ernst, M, Werner, AM, Brähler, E, Wild, PS, Faber, J, Merzenich, H, & Beutel, ME. (2023). Posttraumatic growth after childhood cancer: Psychometric evaluation of a five-item short form and associations with mental health. J Psychosom Res, 164, 111099. doi:10.1016/j.jpsychores.2022.111099
     
  44. *Fahrer, J, & Christmann, M. (2023). DNA Alkylation Damage by Nitrosamines and Relevant DNA Repair Pathways. Int J Mol Sci, 24(5). doi:10.3390/ijms24054684
     
  45. *Foersch, S, Glasner, C, Woerl, AC, Eckstein, M, Wagner, DC, Schulz, S, Kellers, F, Fernandez, A, Tserea, K, Kloth, M, Hartmann, A, Heintz, A, Weichert, W, Roth, W, Geppert, C, Kather, JN, & Jesinghaus, M. (2023). Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer. Nat Med, 29(2), 430-439. doi:10.1038/s41591-022-02134-1
     
  46. Franklin, C, Mohr, P, Bluhm, L, Meier, F, Garzarolli, M, Weichenthal, M, Kähler, K, Grimmelmann, I, Gutzmer, R, Utikal, J, Terheyden, P, Herbst, R, Haferkamp, S, Pfoehler, C, Forschner, A, Leiter, U, Ziller, F, Meiss, F, Ulrich, J, Kreuter, A, Gebhardt, C, Welzel, J, Schilling, B, Kaatz, M, Scharfetter-Kochanek, K, Dippel, E, Nashan, D, Sachse, M, Weishaupt, C, Löffler, H, Gambichler, T, Loquai, C, Heinzerling, L, Grabbe, S, Debus, D, Schley, G, Hassel, JC, Weyandt, G, Trommer, M, Lodde, G, Placke, JM, Zimmer, L, Livingstone, E, Becker, JC, Horn, S, Schadendorf, D, & Ugurel, S. (2023). Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG. J Immunother Cancer, 11(4). doi:10.1136/jitc-2022-005828
     
  47. *Froiio, C, Uzun, E, Hadzijusufovic, E, Capovilla, G, Berlth, F, Lang, H, & Grimminger, PP. (2023). Semiprone thoracoscopic approach during totally minimally invasive Ivor-Lewis esophagectomy seems to be beneficial. Dis Esophagus, 36(2). doi:10.1093/dote/doac044
     
  48. *Gabba, A, Attariya, R, Behren, S, Pett, C, van der Horst, JC, Yurugi, H, Yu, J, Urschbach, M, Sabin, J, Birrane, G, Schmitt, E, van Vliet, SJ, Besenius, P, Westerlind, U, & Murphy, PV. (2023). MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-type Lectin on Dendritic Cells to Elicit an Improved Humoral Response. J Am Chem Soc, 145(24), 13027-13037. doi:10.1021/jacs.2c12843
     
  49. *Galliardt, M, Betz, U, Birklein, F, Drees, P, & Geber, C. (2023). Falls during oxaliplatin-based chemotherapy for gastrointestinal malignancies - (lessons learned from) a prospective study. Open Med (Wars), 18(1), 20230696. doi:10.1515/med-2023-0696
     
  50. *Gerardo-Ramírez, M, Giam, V, Becker, D, Groth, M, Hartmann, N, Morrison, H, May-Simera, HL, Radsak, MP, Marquardt, JU, Galle, PR, Herrlich, P, Straub, BK, & Hartmann, M. (2023). Deletion of Cd44 Inhibits Metastasis Formation of Liver Cancer in Nf2-Mutant Mice. Cells, 12(9). doi:10.3390/cells12091257 
     
  51. Goyal, L, Meric-Bernstam, F, Hollebecque, A, Valle, JW, Morizane, C, Karasic, TB, Abrams, TA, Furuse, J, Kelley, RK, Cassier, PA, Klümpen, HJ, Chang, HM, Chen, LT, Tabernero, J, Oh, DY, Mahipal, A, Moehler, M, Mitchell, EP, Komatsu, Y, Masuda, K, Ahn, D, Epstein, RS, Halim, AB, Fu, Y, Salimi, T, Wacheck, V, He, Y, Liu, M, Benhadji, KA, & Bridgewater, JA. (2023). Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma. N Engl J Med, 388(3), 228-239. doi:10.1056/NEJMoa2206834 
     
  52. Grandt, CL, Brackmann, LK, Foraita, R, Schwarz, H, Hummel-Bartenschlager, W, Hankeln, T, Kraemer, C, Zahnreich, S, Drees, P, Mirsch, J, Spix, C, Blettner, M, Schmidberger, H, Binder, H, Hess, M, Galetzka, D, Marini, F, Poplawski, A, & Marron, M. (2023). Gene expression variability in long-term survivors of childhood cancer and cancer-free controls in response to ionizing irradiation. Mol Med, 29(1), 41. doi:10.1186/s10020-023-00629-2
     
  53. Grandt, CL, Brackmann, LK, Poplawski, A, Schwarz, H, Marini, F, Hankeln, T, Galetzka, D, Zahnreich, S, Mirsch, J, Spix, C, Blettner, M, Schmidberger, H, & Marron, M. (2023). Identification of lncRNAs involved in response to ionizing radiation in fibroblasts of long-term survivors of childhood cancer and cancer-free controls. Front Oncol, 13, 1158176. doi:10.3389/fonc.2023.1158176
     
  54. Gu, Y, Lin, S, Wu, Y, Xu, P, Zhu, W, Wang, Y, Cheng, X, Zhang, LW, Stauber, RH, Wang, Y, & Gao, M. (2023). Targeting STING Activation by Antigen-Inspired MnO(2) Nanovaccines Optimizes Tumor Radiotherapy. Adv Healthc Mater, 12(12), e2300028. doi:10.1002/adhm.202300028
     
  55. *Ha, CSR, Müller-Nurasyid, M, Petrera, A, Hauck, SM, Marini, F, Bartsch, DK, Slater, EP, & Strauch, K. (2023). Proteomics biomarker discovery for individualized prevention of familial pancreatic cancer using statistical learning. PLoS One, 18(1), e0280399. doi:10.1371/journal.pone.0280399
     
  56. Haber, PK, Castet, F, Torres-Martin, M, Andreu-Oller, C, Puigvehí, M, Miho, M, Radu, P, Dufour, JF, Verslype, C, Zimpel, C, Marquardt, JU, Galle, PR, Vogel, A, Bathon, M, Meyer, T, Labgaa, I, Digklia, A, Roberts, LR, Mohamed Ali, MA, Mínguez, B, Citterio, D, Mazzaferro, V, Finkelmeier, F, Trojan, J, Özdirik, B, Müller, T, Schmelzle, M, Bejjani, A, Sung, MW, Schwartz, ME, Finn, RS, Thung, S, Villanueva, A, Sia, D, & Llovet, JM. (2023). Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma. Gastroenterology, 164(1), 72-88.e18. doi:10.1053/j.gastro.2022.09.005
     
  57. *Haist, M, Kaufmann, J, Kur, IM, Zimmer, S, Grabbe, S, Schmidberger, H, Weigert, A, & Mayer, A. (2023). Response to primary chemoradiotherapy of locally advanced oropharyngeal carcinoma is determined by the degree of cytotoxic T cell infiltration within tumor cell aggregates. Front Immunol, 14, 1070203. doi:10.3389/fimmu.2023.1070203
     
  58. *Haist, M, Stege, H, Kuske, M, Bauer, J, Klumpp, A, Grabbe, S, & Bros, M. (2023). Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better? Cancer Metastasis Rev, 42(2), 481-505. doi:10.1007/s10555-023-10097-z
     
  59. *Hamdan, S, Reddehase, MJ, & Holtappels, R. (2023). Cytomegalovirus immune evasion sets the functional avidity threshold for protection by CD8 T cells. Med Microbiol Immunol, 212(2), 153-163. doi:10.1007/s00430-022-00733-w
     
  60. Hauptmann, M, Byrnes, G, Cardis, E, Bernier, MO, Blettner, M, Dabin, J, Engels, H, Istad, TS, Johansen, C, Kaijser, M, Kjaerheim, K, Journy, N, Meulepas, JM, Moissonnier, M, Ronckers, C, Thierry-Chef, I, Le Cornet, L, Jahnen, A, Pokora, R, Bosch de Basea, M, Figuerola, J, Maccia, C, Nordenskjold, A, Harbron, RW, Lee, C, Simon, SL, Berrington de Gonzalez, A, Schüz, J, & Kesminiene, A. (2023). Brain cancer after radiation exposure from CT examinations of children and young adults: results from the EPI-CT cohort study. Lancet Oncol, 24(1), 45-53. doi:10.1016/s1470-2045(22)00655-6
     
  61. *Hausen, A, Huppertz, T, & Gaida, MM. (2023). [Basal cell adenoma of the parotid gland]. Pathologie (Heidelb), 44(1), 1-2. doi:10.1007/s00292-022-01147-4
     
  62. *Heinrich, S, Mittler, J, Theurer, J, Ridder, DA, Marquardt, JU, Weinmann, A, Scheuermann, U, Otto, G, Galle, PR, Straub, BK, & Lang, H. (2023). Microvascular invasion of hepatocellular carcinoma predicts microvascular invasion of its recurrence: potential implications for salvage liver transplantation? Hepatobiliary Surg Nutr, 12(2), 183-191. doi:10.21037/hbsn-21-346
     
  63. Herbert, SL, Flock, F, Felberbaum, R, Janni, W, Löb, S, Kiesel, M, Schlaiß, T, Diessner, J, Curtaz, C, Joukhadar, R, Dayan, D, Schwentner, L, Singer, S, & Wöckel, A. (2023). Predictors of Decreased Quality of Life in Breast Cancer Survivors Five Years After Diagnosis. J Breast Cancer, 26(3), 243-253. doi:10.4048/jbc.2023.26.e23
     
  64. *Herrmann, J, Wessling, D, Nickel, D, Arberet, S, Almansour, H, Afat, C, Afat, S, Gassenmaier, S, & Othman, AE. (2023). Comprehensive Clinical Evaluation of a Deep Learning-Accelerated, Single-Breath-Hold Abdominal HASTE at 1.5 T and 3 T. Acad Radiol, 30(1), 93-102. doi:10.1016/j.acra.2022.03.018
     
  65. Hess, T, Maj, C, Gehlen, J, Borisov, O, Haas, SL, Gockel, I, Vieth, M, Piessen, G, Alakus, H, Vashist, Y, Pereira, C, Knapp, M, Schüller, V, Quaas, A, Grabsch, HI, Trautmann, J, Malecka-Wojciesko, E, Mokrowiecka, A, Speller, J, Mayr, A, Schröder, J, Hillmer, AM, Heider, D, Lordick, F, Pérez-Aísa, Á, Campo, R, Espinel, J, Geijo, F, Thomson, C, Bujanda, L, Sopeña, F, Lanas, Á, Pellisé, M, Pauligk, C, Goetze, TO, Zelck, C, Reingruber, J, Hassanin, E, Elbe, P, Alsabeah, S, Lindblad, M, Nilsson, M, Kreuser, N, Thieme, R, Tavano, F, Pastorino, R, Arzani, D, Persiani, R, Jung, JO, Nienhüser, H, Ott, K, Schumann, RR, Kumpf, O, Burock, S, Arndt, V, Jakubowska, A, Ławniczak, M, Moreno, V, Martín, V, Kogevinas, M, Pollán, M, Dąbrowska, J, Salas, A, Cussenot, O, Boland-Auge, A, Daian, D, Deleuze, JF, Salvi, E, Teder-Laving, M, Tomasello, G, Ratti, M, Senti, C, De Re, V, Steffan, A, Hölscher, AH, Messerle, K, Bruns, CJ, Sīviņš, A, Bogdanova, I, Skieceviciene, J, Arstikyte, J, Moehler, M, Lang, H, Grimminger, PP, Kruschewski, M, Vassos, N, Schildberg, C, Lingohr, P, Ridwelski, K, Lippert, H, Fricker, N, Krawitz, P, Hoffmann, P, Nöthen, MM, Veits, L, Izbicki, JR, Mostowska, A, Martinón-Torres, F, Cusi, D, Adolfsson, R, Cancel-Tassin, G, Höblinger, A, Rodermann, E, Ludwig, M, Keller, G, Metspalu, A, Brenner, H, Heller, J, Neef, M, Schepke, M, Dumoulin, FL, Hamann, L, Cannizzaro, R, Ghidini, M, Plaßmann, D, Geppert, M, Malfertheiner, P, Gehlen, O, Skoczylas, T, Majewski, M, Lubiński, J, Palmieri, O, Boccia, S, Latiano, A, Aragones, N, Schmidt, T, Dinis-Ribeiro, M, Medeiros, R, Al-Batran, SE, Leja, M, Kupcinskas, J, García-González, MA, Venerito, M, & Schumacher, J. (2023). Dissecting the genetic heterogeneity of gastric cancer. EBioMedicine, 92, 104616. doi:10.1016/j.ebiom.2023.104616
     
  66. *Hinz, A, Schulte, T, Ernst, J, Mehnert-Theuerkauf, A, Finck, C, Wondie, Y, & Ernst, M. (2023). Sense of coherence, resilience, and habitual optimism in cancer patients. Int J Clin Health Psychol, 23(2), 100358. doi:10.1016/j.ijchp.2022.100358
     
  67. Hofmann, FO, Heinemann, V, D'Anastasi, M, Gesenhues, AB, Hesse, N, von Weikersthal, LF, Decker, T, Kiani, A, Moehler, M, Kaiser, F, Heintges, T, Kahl, C, Kullmann, F, Scheithauer, W, Link, H, Modest, DP, Stintzing, S, & Holch, JW. (2023). Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3 / AIO KRK-0306. Eur Radiol, 33(2), 1174-1184. doi:10.1007/s00330-022-09053-2
     
  68. Janjigian, YY, Shitara, K, Moehler, M, Garrido, M, Salman, P, Wyrwicz, L, Yamaguchi, K, Skoczylas, T, Bragagnoli, AC, Liu, T, Schenker, M, Yanez, P, Tehfe, M, Kowalyszyn, R, Karamouzis, MV, Bruges, R, Zander, T, Pazo-Cid, R, Hitre, E, Feeney, K, Cleary, JM, Poulart, V, Cullen, D, Lei, M, Xiao, H, Kondo, K, Li, M, & Ajani, JA. (2023). A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus. Future Oncol, 19(11), 739-752. doi:10.2217/fon-2022-1149
     
  69. *Jankovic, D, Kalasauskas, D, Keric, N, Ottenhausen, M, & Ringel, F. (2023). Multiple myeloma presenting as a cervical intraforaminal tumor: A case report and review of literature. Front Surg, 10, 1011152. doi:10.3389/fsurg.2023.1011152
     
  70. *Jartarkar, SR, Cockerell, CJ, Patil, A, Kassir, M, Babaei, M, Weidenthaler-Barth, B, Grabbe, S, & Goldust, M. (2023). Artificial intelligence in Dermatopathology. J Cosmet Dermatol, 22(4), 1163-1167. doi:10.1111/jocd.15565
     
  71. Jeong, YJ, Knutsdottir, H, Shojaeian, F, Lerner, MG, Wissler, MF, Henriet, E, Ng, T, Datta, S, Navarro-Serer, B, Chianchiano, P, Kinny-Köster, B, Zimmerman, JW, Stein-O'Brien, G, Gaida, MM, Eshleman, JR, Lin, MT, Fertig, EJ, Ewald, AJ, Bader, JS, & Wood, LD. (2023). Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that enhance invasion. J Clin Invest, 133(8). doi:10.1172/jci162054
     
  72. *Jung, D, Almstedt, K, Battista, MJ, Seeger, A, Jäkel, J, Brenner, W, & Hasenburg, A. (2023). Immunohistochemical markers of prognosis in adult granulosa cell tumors of the ovary - a review. J Ovarian Res, 16(1), 50. doi:10.1186/s13048-023-01125-1
     
  73. *Kadioglu, O, Bahramimehr, F, Dawood, M, Mahmoud, N, Elbadawi, M, Lu, X, Bülbül, Y, Schulz, JA, Krämer, L, Urschel, MK, Künzli, Z, Abdulrahman, L, Aboumaachar, F, Kadalo, L, Nguyen, LV, Shaidaei, S, Thaher, N, Walter, K, Besler, KC, Spuller, A, Munder, M, Greten, HJ, & Efferth, T. (2023). A drug repurposing approach for individualized cancer therapy based on transcriptome sequencing and virtual drug screening. Comput Biol Med, 157, 106781. doi:10.1016/j.compbiomed.2023.106781
     
  74. *Kämmerer, PW, Tribius, S, Cohrs, L, Engler, G, Ettl, T, Freier, K, Frerich, B, Ghanaati, S, Gosau, M, Haim, D, Hartmann, S, Heiland, M, Herbst, M, Hoefert, S, Hoffmann, J, Hölzle, F, Howaldt, HP, Kreutzer, K, Leonhardt, H, Lutz, R, Moergel, M, Modabber, A, Neff, A, Pietzka, S, Rau, A, Reichert, TE, Smeets, R, Sproll, C, Steller, D, Wiltfang, J, Wolff, KD, Kronfeld, K, & Al-Nawas, B. (2023). Adjuvant Radiotherapy in Patients with Squamous Cell Carcinoma of the Oral Cavity or Oropharynx and Solitary Ipsilateral Lymph Node Metastasis (pN1)-A Prospective Multicentric Cohort Study. Cancers (Basel), 15(6). doi:10.3390/cancers15061833
     
  75. Keller, M, Rohlf, K, Glotzbach, A, Leonhardt, G, Lüke, S, Derksen, K, Demirci, Ö, Göçener, D, AlWahsh, M, Lambert, J, Lindskog, C, Schmidt, M, Brenner, W, Baumann, M, Zent, E, Zischinsky, ML, Hellwig, B, Madjar, K, Rahnenführer, J, Overbeck, N, Reinders, J, Cadenas, C, Hengstler, JG, Edlund, K, & Marchan, R. (2023). Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth. J Exp Clin Cancer Res, 42(1), 25. doi:10.1186/s13046-022-02578-w
     
  76. Khristenko, E, Garcia, EE, Gaida, MM, Hackert, T, Mayer, P, Kauczor, HU, & Klauss, M. (2023). Lymphoepithelial cyst of the pancreas: can common imaging features help to avoid resection? Langenbecks Arch Surg, 408(1), 82. doi:10.1007/s00423-023-02777-9
     
  77. Kleinhaus, H, Brähler, E, Romer, G, & Ernst, J. (2023). [Communicating about Parental Cancer with Minor Children: Necessity, Burden, and Issues from a Parent's Perspective]. Psychother Psychosom Med Psychol, 73(2), 85-88. doi:10.1055/a-1961-1219
     
  78. Klotz, R, Diener, MK, Schmidt, T, Hackert, T, Graf, S, Fuchs, HF, Grimminger, P, Egberts, JH, Gockel, I, van der Sluis, PC, Doerr-Harim, C, Klose, C, Feißt, M, & Mihaljevic, AL. (2023). Overall morbidity after total minimally invasive keyhole oesophagectomy versus hybrid oesophagectomy (the MICkey trial): study protocol for a multicentre randomized controlled trial. Trials, 24(1), 175. doi:10.1186/s13063-023-07134-1
     
  79. *Kneist, W, Ghadimi, M, Runkel, N, Moesta, T, Coerper, S, Benecke, C, Kauff, DW, Gretschel, S, Gockel, I, Jansen-Winkeln, B, Lang, H, Gorbulev, S, Ruckes, C, & Kronfeld, K. (2023). Pelvic Intraoperative Neuromonitoring Prevents Dysfunction in Patients With Rectal Cancer: Results From a Multicenter, Randomized, Controlled Clinical Trial of a NEUROmonitoring System (NEUROS). Ann Surg, 277(4), e737-e744. doi:10.1097/sla.0000000000005676
     
  80. *Koehler, C, Sauter, PF, Klasen, B, Waldmann, C, Pektor, S, Bausbacher, N, Lemke, EA, & Miederer, M. (2023). Genetic Code Expansion for Site-Specific Labeling of Antibodies with Radioisotopes. ACS Chem Biol, 18(3), 443-448. doi:10.1021/acschembio.2c00634
     
  81. *Koll, L, Gül, D, Elnouaem, MI, Raslan, H, Ramadan, OR, Knauer, SK, Strieth, S, Hagemann, J, Stauber, RH, & Khamis, A. (2023). Exploiting Vitamin D Receptor and Its Ligands to Target Squamous Cell Carcinomas of the Head and Neck. Int J Mol Sci, 24(5). doi:10.3390/ijms24054675
     
  82. *Krajnak, S, Krajnakova, J, Anic, K, Almstedt, K, Heimes, AS, Linz, VC, Loewe, A, Schmidt, MW, Hasenburg, A, Schmidt, M, & Battista, MJ. (2023). Real-World Experience of Metronomic Chemotherapy in Metastatic Breast Cancer: Results of a Retrospective Unicenter Study. Breast Care (Basel), 18(2), 97-105. doi:10.1159/000528042
     
  83. *Krajnak, S, Trier, JP, Heinzmann, PF, Anic, K, Heimes, AS, Loewe, A, Schmidt, M, Battista, MJ, Hasenburg, A, & Brenner, W. (2023). Anti-tumor effects of low-dose metronomic vinorelbine in combination with alpelisib in breast cancer cells. Excli j, 22, 114-130. doi:10.17179/excli2022-5064
     
  84. Kramer, ED, Tzetzo, SL, Colligan, SH, Hensen, ML, Brackett, CM, Clausen, BE, Taketo, MM, & Abrams, SI. (2023). β-Catenin signaling in alveolar macrophages enhances lung metastasis through a TNF-dependent mechanism. JCI Insight, 8(8). doi:10.1172/jci.insight.160978
     
  85. *Kreft, A, Schulze, L, Ries, I, Schindeldecker, M, & Neumann, H. (2023). Histological diagnosis of acute graft-versus-host disease in different sites of the upper gastrointestinal tract with correlation to endoscopic findings. Leuk Lymphoma, 64(2), 433-439. doi:10.1080/10428194.2022.2142056
     
  86. Kroese, TE, van Laarhoven, HWM, Schoppman, SF, Deseyne, P, van Cutsem, E, Haustermans, K, Nafteux, P, Thomas, M, Obermannova, R, Mortensen, HR, Nordsmark, M, Pfeiffer, P, Elme, A, Adenis, A, Piessen, G, Bruns, CJ, Lordick, F, Gockel, I, Moehler, M, Gani, C, Liakakos, T, Reynolds, J, Morganti, AG, Rosati, R, Castoro, C, Cellini, F, D'Ugo, D, Roviello, F, Bencivenga, M, de Manzoni, G, van Berge Henegouwen, MI, Hulshof, M, van Dieren, J, Vollebergh, M, van Sandick, JW, Jeene, P, Muijs, CT, Slingerland, M, Voncken, FEM, Hartgrink, H, Creemers, GJ, van der Sangen, MJC, Nieuwenhuijzen, G, Berbee, M, Verheij, M, Wijnhoven, B, Beerepoot, LV, Mohammad, NH, Mook, S, Ruurda, JP, Kolodziejczyk, P, Polkowski, WP, Wyrwicz, L, Alsina, M, Pera, M, Kanonnikoff, TF, Cervantes, A, Nilsson, M, Monig, S, Wagner, AD, Guckenberger, M, Griffiths, EA, Smyth, E, Hanna, GB, Markar, S, Chaudry, MA, Hawkins, MA, Cheong, E, van Hillegersberg, R, & van Rossum, PSN. (2023). Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe. Eur J Cancer, 185, 28-39. doi:10.1016/j.ejca.2023.02.015
     
  87. Kroese, TE, van Rossum, PSN, Nilsson, M, Lordick, F, Smyth, EC, Rosati, R, Nafteux, P, D'Ugo, D, Chaudry, MA, Polkowkski, W, Roviello, F, Gockel, I, Kolodziejczyk, P, Haustermans, K, Guckenberger, M, Nordsmark, M, Hawkins, MA, Cervantes, A, Fleitas, T, van Cutsem, E, Moehler, M, Wagner, AD, van Laarhoven, HWM, & van Hillegersberg, R. (2023). Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer. Eur J Surg Oncol, 49(1), 21-28. doi:10.1016/j.ejso.2022.09.012
     
  88. Kroone, C, Tieken, C, Kocatürk, B, Paauwe, M, Blok, EJ, Ünlü, B, van den Berg, YW, Stanganello, E, Kapteijn, MY, Swier, N, Zhang, X, Duits, DEM, Lin, Y, Oostenbrink, LVE, van den Akker, RFP, Mosnier, LO, Hawinkels, LJ, van Vlijmen, BJM, Ruf, W, Kuppen, PJ, Cannegieter, SC, Buijs, JT, & Versteeg, HH. (2023). Tumor-expressed factor VII is associated with survival and regulates tumor progression in breast cancer. Blood Adv, 7(11), 2388-2400. doi:10.1182/bloodadvances.2022008455
     
  89. *Kuehn, M, Wypyrsczyk, L, Stoessel, S, Neu, MA, Ploch, L, Dreismickenbecker, E, Simon, P, & Faber, J. (2023). Physical Activity as a Treatment for Cancer-Related Fatigue in Children, Adolescents and Young Adults: A Systematic Review. Children (Basel), 10(3). doi:10.3390/children10030572
     
  90. *Kumari, J, Das, K, Patil, A, Babaei, M, Cockerell, CJ, & Goldust, M. (2023). Clinical update on cutaneous and subcutaneous sarcomas. J Cosmet Dermatol, 22(2), 402-409. doi:10.1111/jocd.15369
     
  91. Lam, LL, Pavlakis, N, Shitara, K, Sjoquist, KM, Martin, AJ, Yip, S, Kang, YK, Bang, YJ, Chen, LT, Moehler, M, Bekaii-Saab, T, Alcindor, T, O'Callaghan, CJ, Tebbutt, NC, Hague, W, Chan, H, Rha, SY, Lee, KW, Gebski, V, Jaworski, A, Zalcberg, J, Price, T, Simes, J, & Goldstein, D. (2023). INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG). BMC Cancer, 23(1), 180. doi:10.1186/s12885-023-10642-7
     
  92. Lee, OW, Rodrigues, C, Lin, SH, Luo, W, Jones, K, Brown, DW, Zhou, W, Karlins, E, Khan, SM, Baulande, S, Raynal, V, Surdez, D, Reynaud, S, Rubio, RA, Zaidi, S, Grossetête, S, Ballet, S, Lapouble, E, Laurence, V, Pierron, G, Gaspar, N, Corradini, N, Marec-Bérard, P, Rothman, N, Dagnall, CL, Burdett, L, Manning, M, Wyatt, K, Yeager, M, Chari, R, Leisenring, WM, Kulozik, AE, Kriebel, J, Meitinger, T, Strauch, K, Kirchner, T, Dirksen, U, Mirabello, L, Tucker, MA, Tirode, F, Armstrong, GT, Bhatia, S, Robison, LL, Yasui, Y, Romero-Pérez, L, Hartmann, W, Metzler, M, Diver, WR, Lori, A, Freedman, ND, Hoover, RN, Morton, LM, Chanock, SJ, Grünewald, TGP, Delattre, O, & Machiela, MJ. (2023). Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding. Am J Hum Genet, 110(3), 427-441. doi:10.1016/j.ajhg.2023.01.017
     
  93. Li, J, Tajuddeen, N, Feineis, D, Mudogo, V, Kaiser, M, Seo, EJ, Efferth, T, & Bringmann, G. (2023). Jozibrevine D from Ancistrocladus ileboensis, the fifth alkaloid in a series of six possible atropo-diastereomeric naphthylisoquinoline dimers, showing antiparasitic and antileukemic activities. Bioorg Med Chem Lett, 86, 129258. doi:10.1016/j.bmcl.2023.129258
     
  94. *Linz, VC, Schwanbeck, C, Krajnak, S, Anic, K, Jäkel, J, Schwab, R, Schmidt, M, Schmidberger, H, Hasenburg, A, & Battista, MJ. (2023). Comparison of cisplatin and mitomycin C/5-FU as radiosensitisers in the treatment of locally advanced vulvar cancer: results of a retrospective, observational, single-institutional cohort study. J Cancer Res Clin Oncol, 149(4), 1391-1399. doi:10.1007/s00432-022-04006-0
     
  95. Lorenzen, S, Schwarz, A, Pauligk, C, Goekkurt, E, Stocker, G, Knorrenschild, JR, Illerhaus, G, Dechow, T, Moehler, M, Moulin, JC, Pink, D, Stahl, M, Schaaf, M, Goetze, TO, & Al-Batran, SE. (2023). Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415). BMC Cancer, 23(1), 561. doi:10.1186/s12885-023-11004-z
     
  96. Lutz, V, Hellmund, VM, Picard, FSR, Raifer, H, Ruckenbrod, T, Klein, M, Bopp, T, Savai, R, Duewell, P, Keber, CU, Weigert, A, Chung, HR, Buchholz, M, Menke, A, Gress, TM, Huber, M, & Bauer, C. (2023). IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model. Cancer Immunol Res, 11(4), 421-434. doi:10.1158/2326-6066.Cir-22-0398
     
  97. Mai, EK, Huhn, S, Miah, K, Poos, AM, Scheid, C, Weisel, KC, Bertsch, U, Munder, M, Berlanga, O, Hose, D, Seckinger, A, Jauch, A, Blau, IW, Hänel, M, Salwender, HJ, Benner, A, Raab, MS, Goldschmidt, H, & Weinhold, N. (2023). Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood Cancer J, 13(1), 1. doi:10.1038/s41408-022-00772-9
     
  98. Maier, D, Vehreschild, JJ, Uhl, B, Meyer, S, Berger-Thürmel, K, Boerries, M, Braren, R, Grünwald, V, Hadaschik, B, Palm, S, Singer, S, Stuschke, M, Juárez, D, Delpy, P, Lambarki, M, Hummel, M, Engels, C, Andreas, S, Gökbuget, N, Ihrig, K, Burock, S, Keune, D, Eggert, A, Keilholz, U, Schulz, H, Büttner, D, Löck, S, Krause, M, Esins, M, Ressing, F, Schuler, M, Brandts, C, Brucker, DP, Husmann, G, Oellerich, T, Metzger, P, Voigt, F, Illert, AL, Theobald, M, Kindler, T, Sudhof, U, Reckmann, A, Schwinghammer, F, Nasseh, D, Weichert, W, von Bergwelt-Baildon, M, Bitzer, M, Malek, N, Öner, Ö, Schulze-Osthoff, K, Bartels, S, Haier, J, Ammann, R, Schmidt, AF, Guenther, B, Janning, M, Kasper, B, Loges, S, Stilgenbauer, S, Kuhn, P, Tausch, E, Runow, S, Kerscher, A, Neumann, M, Breu, M, Lablans, M, & Serve, H. (2023). Profile of the multicenter cohort of the German Cancer Consortium's Clinical Communication Platform. Eur J Epidemiol, 38(5), 573-586. doi:10.1007/s10654-023-00990-w
     
  99. Mosconi, C, O'Rourke, J, Kloeckner, R, Sturm, L, Golfieri, R, Celsa, C, Fateen, W, Odisio, BC, Garanzini, EM, Peck-Radosavljevic, M, Borghi, A, Ma, YT, Stoehr, F, Bettinger, D, Giuffrida, P, Aithal, GP, Lin, YM, Spreafico, C, Giampalma, E, Johnson, P, & Cucchetti, A. (2023). Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular Carcinoma. Cardiovasc Intervent Radiol, 46(4), 449-459. doi:10.1007/s00270-023-03375-4
     
  100. *Müller, A, Weyerhäuser, P, Berte, N, Jonin, F, Lyubarskyy, B, Sprang, B, Kantelhardt, SR, Salinas, G, Opitz, L, Schulz-Schaeffer, W, Giese, A, & Kim, EL. (2023). Concurrent Activation of Both Survival-Promoting and Death-Inducing Signaling by Chloroquine in Glioblastoma Stem Cells: Implications for Potential Risks and Benefits of Using Chloroquine as Radiosensitizer. Cells, 12(9). doi:10.3390/cells12091290
     
  101. *Müller, L, Gairing, SJ, Foerster, F, Weinmann, A, Mittler, J, Stoehr, F, Graafen, D, Düber, C, Galle, PR, Kloeckner, R, & Hahn, F. (2023). Portal hypertension in patients with hepatocellular carcinoma and immunotherapy: prognostic relevance of CT-morphologic estimates. Cancer Imaging, 23(1), 40. doi:10.1186/s40644-023-00558-7
     
  102. *Müller, L, Mähringer-Kunz, A, Auer, TA, Fehrenbach, U, Gebauer, B, Haubold, J, Theysohn, JM, Kim, MS, Kleesiek, J, Diallo, TD, Eisenblätter, M, Bettinger, D, Steinle, V, Mayer, P, Zopfs, D, Pinto Dos Santos, D, & Kloeckner, R. (2023). Low bone mineral density is a prognostic factor for elderly patients with HCC undergoing TACE: results from a multicenter study. Eur Radiol, 33(2), 1031-1039. doi:10.1007/s00330-022-09069-8 
     
  103. *Mustafa, AM, Ashry, R, & Krämer, OH. (2023). Monitoring Changes in Intracellular Reactive Oxygen Species Levels in Response to Histone Deacetylase Inhibitors. Methods Mol Biol, 2589, 337-344. doi:10.1007/978-1-0716-2788-4_22
     
  104. *Mustafa, AM, & Krämer, OH. (2023). Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer. Pharmacol Rev, 75(1), 35-61. doi:10.1124/pharmrev.122.000612
     
  105. Neuberger, M, Frey, L, Nitschke, K, Wessels, F, Westhoff, N, Waldbillig, F, Nientiedt, M, Hartung, F, J, VONH, Michel, MS, Erben, P, Nuhn, P, & Worst, TS. (2023). Integrin Expression in Localized Prostate Cancer: A TCGA and MSKCC Cohort-based Exploratory In Silico Analysis. Anticancer Res, 43(1), 417-428. doi:10.21873/anticanres.16177
     
  106. Niehues, JM, Quirke, P, West, NP, Grabsch, HI, van Treeck, M, Schirris, Y, Veldhuizen, GP, Hutchins, GGA, Richman, SD, Foersch, S, Brinker, TJ, Fukuoka, J, Bychkov, A, Uegami, W, Truhn, D, Brenner, H, Brobeil, A, Hoffmeister, M, & Kather, JN. (2023). Generalizable biomarker prediction from cancer pathology slides with self-supervised deep learning: A retrospective multi-centric study. Cell Rep Med, 4(4), 100980. doi:10.1016/j.xcrm.2023.100980
     
  107. Noske, A, Steiger, K, Ballke, S, Kiechle, M, Oettler, D, Roth, W, & Weichert, W. (2023). Comparison of assessment of programmed death-ligand 1 (PD-L1) status in triple-negative breast cancer biopsies and surgical specimens. J Clin Pathol. doi:10.1136/jcp-2022-208637
     
  108. Oelschläger, L, Stahl, P, Kaschani, F, Stauber, RH, Knauer, SK, & Hensel, A. (2023). Taspase1 Facilitates Topoisomerase IIβ-Mediated DNA Double-Strand Breaks Driving Estrogen-Induced Transcription. Cells, 12(3). doi:10.3390/cells12030363
     
  109. Oertel, M, Berdel, C, Held, G, Herfarth, K, Schmidberger, H, Ernst, M, Lenz, G, Borchmann, P, & Eich, HT. (2023). The new German evidence-based guideline on diffuse large B-cell lymphoma-key aspects for radiation oncologists. Strahlenther Onkol, 199(2), 115-120. doi:10.1007/s00066-022-02035-9
     
  110. Omlin, A, Cathomas, R, von Amsberg, G, Reuter, C, Feyerabend, S, Loidl, W, Boegemann, M, Lorch, A, Heidenreich, A, Tsaur, I, Larcher-Senn, J, Buck, SAJ, Mathijssen, RHJ, Jaehde, U, Gillessen, S, & Joerger, M. (2023). Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res, 29(10), 1887-1893. doi:10.1158/1078-0432.Ccr-22-3360
     
  111. *Ottenhausen, M, Conrad, J, Wolters, LM, & Ringel, F. (2023). Surgery as first-line treatment for prolactinoma? Discussion of the literature and results of a consecutive series of surgically treated patients. Neurosurg Rev, 46(1), 128. doi:10.1007/s10143-023-02033-0
     
  112. *Ottenhausen, M, Greco, E, Bertolini, G, Gerosa, A, Ippolito, S, Middlebrooks, EH, Serrao, G, Bruzzone, MG, Costa, F, Ferroli, P, & La Corte, E. (2023). Craniovertebral Junction Instability after Oncological Resection: A Narrative Review. Diagnostics (Basel), 13(8). doi:10.3390/diagnostics13081502
     
  113. *Özenver, N, & Efferth, T. (2023). Identification of Prognostic and Predictive Biomarkers and Druggable Targets among 205 Antioxidant Genes in 21 Different Tumor Types via Data-Mining. Pharmaceutics, 15(2). doi:10.3390/pharmaceutics15020427
     
  114. *Penzkofer, L, Gröger, LK, Hoppe-Lotichius, M, Baumgart, J, Heinrich, S, Mittler, J, Gerber, TS, Straub, BK, Weinmann, A, Bartsch, F, & Lang, H. (2023). Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single Center. Cancers (Basel), 15(3). doi:10.3390/cancers15030639
     
  115. *Penzkofer, L, Huber, T, Mittler, J, Lang, H, & Heinrich, S. (2023). [Liver Resections Can Be Safely Performed in Cirrhotic Patients after Careful Patient Selection]. Zentralbl Chir, 148(2), 156-164. doi:10.1055/a-1373-6218
     
  116. Petropoulos, M, Champeris Tsaniras, S, Nikou, S, Maxouri, S, Dionellis, VS, Kalogeropoulou, A, Karamichali, A, Ioannidis, K, Danalatos, IR, Obst, M, Naumann, R, Delinasios, GJ, Gorgoulis, VG, Roukos, V, Anastassiadis, K, Halazonetis, TD, Bravou, V, Lygerou, Z, & Taraviras, S. (2023). Cdt1 overexpression drives colorectal carcinogenesis through origin overlicensing and DNA damage. J Pathol, 259(1), 10-20. doi:10.1002/path.6017
     
  117. Pfisterer, J, Joly, F, Kristensen, G, Rau, J, Mahner, S, Pautier, P, El-Balat, A, Kurtz, JE, Canzler, U, Sehouli, J, Heubner, ML, Hartkopf, AD, Baumann, K, Hasenburg, A, Hanker, LC, Belau, A, Schmalfeldt, B, Denschlag, D, Park-Simon, TW, Selle, F, Jackisch, C, Burges, A, Lück, HJ, Emons, G, Meier, W, Gropp-Meier, M, Schröder, W, de Gregorio, N, Hilpert, F, & Harter, P. (2023). Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial. J Clin Oncol, 41(4), 893-902. doi:10.1200/jco.22.01010
     
  118. *Pielenhofer, J, Meiser, SL, Gogoll, K, Ciciliani, AM, Denny, M, Klak, M, Lang, BM, Staubach, P, Grabbe, S, Schild, H, Radsak, MP, Spahn-Langguth, H, & Langguth, P. (2023). Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product. Pharmaceutics, 15(2). doi:10.3390/pharmaceutics15020514
     
  119. Pomej, K, Balcar, L, Shmanko, K, Welland, S, Himmelsbach, V, Scheiner, B, Mahyera, A, Mozayani, B, Trauner, M, Finkelmeier, F, Weinmann, A, Vogel, A, & Pinter, M. (2023). Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma-a European multicenter cohort. ESMO Open, 8(1), 100783. doi:10.1016/j.esmoop.2023.100783
     
  120. Qu, YQ, Song, LL, Xu, SW, Yu, MSY, Kadioglu, O, Michelangeli, F, Law, BYK, Efferth, T, Lam, CW, & Wong, VKW. (2023). Pomiferin targets SERCA, mTOR, and P-gp to induce autophagic cell death in apoptosis-resistant cancer cells, and reverses the MDR phenotype in cisplatin-resistant tumors in vivo. Pharmacol Res, 191, 106769. doi:10.1016/j.phrs.2023.106769
     
  121. *Rashan, LJ, Özenver, N, Boulos, JC, Dawood, M, Roos, WP, Franke, K, Papasotiriou, I, Wessjohann, LA, Fiebig, HH, & Efferth, T. (2023). Molecular Modes of Action of an Aqueous Nerium oleander Extract in Cancer Cells In Vitro and In Vivo. Molecules, 28(4). doi:10.3390/molecules28041871
     
  122. Redmond, KJ, Schaub, SK, Lo, SL, Khan, M, Lubelski, D, Bilsky, M, Yamada, Y, Fehlings, M, Gogineni, E, Vajkoczy, P, Ringel, F, Meyer, B, Amin, AG, Combs, SE, & Lo, SS. (2023). Radiotherapy for Mobile Spine and Sacral Chordoma: A Critical Review and Practical Guide from the Spine Tumor Academy. Cancers (Basel), 15(8). doi:10.3390/cancers15082359
     
  123. Reis, J, Travado, L, Scherrer, A, Kosmidis, T, Venios, S, Laras, PE, Oestreicher, G, Moehler, M, Parolini, M, Passardi, A, Meggiolaro, E, Martinelli, G, Petracci, E, Zingaretti, C, Diamantopoulos, S, Plakia, M, Vassiliou, C, Mousa, S, Zifrid, R, Sullo, FG, & Gallio, C. (2023). Digital Guardian Angel Supported by an Artificial Intelligence System to Improve Quality of Life, Well-being, and Health Outcomes of Patients With Cancer (ONCORELIEF): Protocol for a Single Arm Prospective Multicenter Pilot Study. JMIR Res Protoc, 12, e45475. doi:10.2196/45475
     
  124. *Ressing, M, Becker, C, Müller, C, Mahmoudpour, SH, Calaminus, G, Langer, T, Erdmann, F, Voigt, M, Kaiser, M, Kaatsch, P, Blettner, M, & Spix, C. (2023). Equivalent doses for anticancer agents used in pediatric oncology: A literature review and evaluation of a novel approach for conversion factors. Cancer Rep (Hoboken), 6(5), e1811. doi:10.1002/cnr2.1811
     
  125. Rojas, LA, Sethna, Z, Soares, KC, Olcese, C, Pang, N, Patterson, E, Lihm, J, Ceglia, N, Guasp, P, Chu, A, Yu, R, Chandra, AK, Waters, T, Ruan, J, Amisaki, M, Zebboudj, A, Odgerel, Z, Payne, G, Derhovanessian, E, Müller, F, Rhee, I, Yadav, M, Dobrin, A, Sadelain, M, Łuksza, M, Cohen, N, Tang, L, Basturk, O, Gönen, M, Katz, S, Do, RK, Epstein, AS, Momtaz, P, Park, W, Sugarman, R, Varghese, AM, Won, E, Desai, A, Wei, AC, D'Angelica, MI, Kingham, TP, Mellman, I, Merghoub, T, Wolchok, JD, Sahin, U, Türeci, Ö, Greenbaum, BD, Jarnagin, WR, Drebin, J, O'Reilly, EM, & Balachandran, VP. (2023). Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature, 618(7963), 144-150. doi:10.1038/s41586-023-06063-y
     
  126. *Rosellini, M, Turunen, P, & Efferth, T. (2023). Impact of Plastic-Related Compounds on P-Glycoprotein and Breast Cancer Resistance Protein In Vitro. Molecules, 28(6). doi:10.3390/molecules28062710
     
  127. Roser, E, Harter, P, Zocholl, D, Denschlag, D, Chekerov, R, Wimberger, P, Kurzeder, C, Hasenburg, A, Muallem, MZ, Mustea, A, Emons, G, Zeimet, AG, Beck, F, Arndt, T, Brucker, SY, Kommoss, S, Heitz, F, Welz, J, Egger, EK, Kalder, M, Buderath, P, Klar, M, Marth, C, Ulrich, UA, Weigel, M, Traub, L, Anthuber, C, Strauss, H, Hanker, L, Link, T, Kubiak, K, Melekian, B, Hornung, D, Pölcher, M, Lampe, B, Krauß, T, Keilholz, U, Flörcken, A, Pietzner, K, & Sehouli, J. (2023). Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1). Int J Gynecol Cancer, 33(2), 223-230. doi:10.1136/ijgc-2022-003800
     
  128. Rühle, A, Marschner, S, Haderlein, M, Fabian, A, Weymann, M, Behrens, M, Senger, C, Dickstein, DR, Kraft, J, von der Grün, J, Chen, E, Aquino-Michaels, T, Domschikowski, J, Bickel, A, Altay-Langguth, A, Kalinauskaite, G, Lewitzki, V, Ferentinos, K, Zamboglou, C, Schnellhardt, S, Haehl, E, Spohn, SKB, Gkika, E, Zöller, D, Guckenberger, M, Budach, V, Belka, C, Bakst, R, Mayer, A, Schmidberger, H, Grosu, AL, Balermpas, P, Stromberger, C, & Nicolay, NH. (2023). Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy. JAMA Netw Open, 6(2), e230090. doi:10.1001/jamanetworkopen.2023.0090
     
  129. *Russo, A, Blettner, M, Merzenich, H, Wollschlaeger, D, Erdmann, F, & Gianicolo, E. (2023). Incidence of childhood leukemia before and after shut down of nuclear power plants in Germany in 2011: A population-based register study during 2004 to 2019. Int J Cancer, 152(5), 913-920. doi:10.1002/ijc.34303
     
  130. Saldanha, OL, Muti, HS, Grabsch, HI, Langer, R, Dislich, B, Kohlruss, M, Keller, G, van Treeck, M, Hewitt, KJ, Kolbinger, FR, Veldhuizen, GP, Boor, P, Foersch, S, Truhn, D, & Kather, JN. (2023). Direct prediction of genetic aberrations from pathology images in gastric cancer with swarm learning. Gastric Cancer, 26(2), 264-274. doi:10.1007/s10120-022-01347-0
     
  131. Salzmann, M, Wald, A, Stege, H, Loquai, C, Zimmer, L, Hayani, KM, Heinzerling, L, Gutzmer, R, Enk, AH, & Hassel, JC. (2023). Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study. Cancers (Basel), 15(5). doi:10.3390/cancers15051426
     
  132. Schaarschmidt, BM, Kloeckner, R, Dertnig, T, Demircioglu, A, Müller, L, Auer, TA, Santos, DPD, Steinle, V, Miederer, M, Gebauer, B, Radunz, S, Kasper, S, Weber, M, & Theysohn, J. (2023). Real-Life Experience in the Treatment of Intrahepatic Cholangiocarcinoma by (90)Y Radioembolization: A Multicenter Retrospective Study. J Nucl Med, 64(4), 529-535. doi:10.2967/jnumed.122.264598
     
  133. Schlaiss, T, Singer, S, Herbert, SL, Diessner, J, Bartmann, C, Kiesel, M, Janni, W, Kuehn, T, Flock, F, Felberbaum, R, Schwentner, L, Leinert, E, & Woeckel, A. (2023). Psycho-Oncological Care Provision in Highly Distressed Breast Cancer Patients. Geburtshilfe Frauenheilkd, 83(6), 702-707. doi:10.1055/a-2044-0072
     
  134. Schröder, J, Chegwidden, L, Maj, C, Gehlen, J, Speller, J, Böhmer, AC, Borisov, O, Hess, T, Kreuser, N, Venerito, M, Alakus, H, May, A, Gerges, C, Schmidt, T, Thieme, R, Heider, D, Hillmer, AM, Reingruber, J, Lyros, O, Dietrich, A, Hoffmeister, A, Mehdorn, M, Lordick, F, Stocker, G, Hohaus, M, Reim, D, Kandler, J, Müller, M, Ebigbo, A, Fuchs, C, Bruns, CJ, Hölscher, AH, Lang, H, Grimminger, PP, Dakkak, D, Vashist, Y, May, S, Görg, S, Franke, A, Ellinghaus, D, Galavotti, S, Veits, L, Weismüller, J, Dommermuth, J, Benner, U, Rösch, T, Messmann, H, Schumacher, B, Neuhaus, H, Schmidt, C, Wissinowski, TT, Nöthen, MM, Dong, J, Ong, JS, Buas, MF, Thrift, AP, Vaughan, TL, Tomlinson, I, Whiteman, DC, Fitzgerald, RC, Jankowski, J, Vieth, M, Mayr, A, Gharahkhani, P, MacGregor, S, Gockel, I, Palles, C, & Schumacher, J. (2023). GWAS meta-analysis of 16 790 patients with Barrett's oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker level. Gut, 72(4), 612-623. doi:10.1136/gutjnl-2021-326698
     
  135. *Schrörs, B, Hos, BJ, Yildiz, IG, Löwer, M, Lang, F, Holtsträter, C, Becker, J, Vormehr, M, Sahin, U, Ossendorp, F, & Diken, M. (2023). MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression. Front Immunol, 14, 1102282. doi:10.3389/fimmu.2023.1102282
     
  136. Schumann, K, Mauch, C, Klespe, KC, Loquai, C, Nikfarjam, U, Schlaak, M, Akçetin, L, Kölblinger, P, Hoellwerth, M, Meissner, M, Mengi, G, Braun, AD, Mengoni, M, Dummer, R, Mangana, J, Sindrilaru, MA, Radmann, D, Hafner, C, Freund, J, Rappersberger, K, Weihsengruber, F, Meiss, F, Reinhardt, L, Meier, F, Rainer, B, Richtig, E, Ressler, JM, Höller, C, Eigentler, T, Amaral, T, Peitsch, WK, Hillen, U, Harth, W, Ziller, F, Schatton, K, Gambichler, T, Susok, L, Maul, LV, Läubli, H, Debus, D, Weishaupt, C, Börger, S, Sievers, K, Haferkamp, S, Zenderowski, V, Nguyen, VA, Wanner, M, Gutzmer, R, Terheyden, P, Kähler, K, Emmert, S, Thiem, A, Sachse, M, Gercken-Riedel, S, Kaune, KM, Thoms, KM, Heinzerling, L, Heppt, MV, Tratzmiller, S, Hoetzenecker, W, Öllinger, A, Steiner, A, Peinhaupt, T, Podda, M, Schmid, S, Wollina, U, Biedermann, T, & Posch, C. (2023). Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland. J Eur Acad Dermatol Venereol, 37(5), 894-906. doi:10.1111/jdv.18779
     
  137. *Schwab, R, Stewen, K, Bührer, TL, Schmidt, MW, van der Ven, J, Anic, K, Linz, VC, Hamoud, BH, Brenner, W, Peters, K, Heimes, AS, Almstedt, K, Krajnak, S, Weikel, W, Battista, MJ, Dannecker, C, & Hasenburg, A. (2023). Current Approaches to the Management of Sentinel Node Procedures in Early Vulvar Cancer in Germany: A Web-Based Nationwide Analysis of Practices. J Clin Med, 12(5). doi:10.3390/jcm12052048
     
  138. *Seifen, C, Matthias, C, & O'Brien, K. (2023). Massive nasopharyngeal rhabdomyosarcoma in an adult patient: a rare case report. Oxf Med Case Reports, 2023(1), omac148. doi:10.1093/omcr/omac148
     
  139. Sigismondo, G, Arseni, L, Palacio-Escat, N, Hofmann, TG, Seiffert, M, & Krijgsveld, J. (2023). Multi-layered chromatin proteomics identifies cell vulnerabilities in DNA repair. Nucleic Acids Res, 51(2), 687-711. doi:10.1093/nar/gkac1264
     
  140. *Singer, S, Janni, W, Kühn, T, Flock, F, Felberbaum, R, Schwentner, L, Leinert, E, Wöckel, A, & Schlaiß, T. (2023). Awareness, offer, and use of psychosocial services by breast cancer survivors in Germany: a prospective multi-centre study. Arch Gynecol Obstet, 307(3), 945-956. doi:10.1007/s00404-022-06665-3
     
  141. *Singer, S, Riccetti, N, Hempler, I, Fried, M, Knorrenschild, JR, Kalie, L, Merbach, M, Reiser, M, Mosthaf, F, Heidt, V, & Hermes-Moll, K. (2023). Awareness and use of psychosocial care among cancer patients and their relatives-a comparison of people with and without a migration background in Germany. J Cancer Res Clin Oncol, 149(5), 1733-1745. doi:10.1007/s00432-022-04091-1
     
  142. Sonneveld, P, Chanan-Khan, A, Weisel, K, Nooka, AK, Masszi, T, Beksac, M, Spicka, I, Hungria, V, Munder, M, Mateos, MV, Mark, TM, Levin, MD, Ahmadi, T, Qin, X, Garvin Mayo, W, Gai, X, Carey, J, Carson, R, & Spencer, A. (2023). Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial. J Clin Oncol, 41(8), 1600-1609. doi:10.1200/jco.21.02734
     
  143. *Spix, C, Erdmann, F, Grabow, D, & Ronckers, C. (2023). Childhood and adolescent cancer in Germany - an overview. J Health Monit, 8(2), 79-94. doi:10.25646/11438
     
  144. *Stanganello, E, Brkic, M, Zenner, S, Beulshausen, I, Schmitt, U, & Vascotto, F. (2023). Protocol for the murine antibody-dependent cellular phagocytosis assay. Methods Cell Biol, 173, 109-120. doi:10.1016/bs.mcb.2022.05.006
     
  145. *Staubitz, JI, Müller, C, Heymans, A, Merten, C, Roos, B, Poplawski, A, Ludt, A, Strobl, S, Springer, E, Schad, A, Roth, W, Musholt, TJ, & Hartmann, N. (2023). Approach to risk stratification for papillary thyroid carcinoma based on molecular profiling: institutional analysis. BJS Open, 7(3). doi:10.1093/bjsopen/zrad029
     
  146. Stern, L, Boehme, LF, Goetz, MR, Nitschke, C, Giannou, A, Zhang, T, Güngör, C, Reeh, M, Izbicki, JR, Fliegert, R, Hausen, A, Giese, N, Hackert, T, Niv, MY, Heinrich, S, Gaida, MM, & Ghadban, T. (2023). Potential role of the bitter taste receptor T2R14 in the prolonged survival and enhanced chemoresponsiveness induced by apigenin. Int J Oncol, 62(1). doi:10.3892/ijo.2022.5454
     
  147. Stolze, J, Raber-Durlacher, JE, Loonen, JJ, Teepen, JC, Ronckers, CM, Tissing, WJE, de Vries, ACH, Neggers, S, Dulmen-den Broeder, E, Heuvel-Eibrink, MM, van der Pal, HJH, Versluys, AB, Heiden-van der Loo, M, Louwerens, M, Kremer, LCM, Bresters, D, & Brand, HS. (2023). Self-reported outcomes on oral health and oral health-related quality of life in long-term childhood cancer survivors-A DCCSS-LATER 2 Study. Support Care Cancer, 31(6), 344. doi:10.1007/s00520-023-07797-1
     
  148. Stolze, T, Franke, S, Haybaeck, J, Moehler, M, Grimminger, PP, Lang, H, Roth, W, Gockel, I, Kreuser, N, Bläker, H, Wittekind, C, Lordick, F, Vieth, M, Veits, L, Waidmann, O, Lingohr, P, Peitz, U, Schildberg, C, Kruschewski, M, Vassos, N, Goni, E, Bruns, CJ, Ridwelski, K, Wolff, S, Lippert, H, Schumacher, J, Malfertheiner, P, & Venerito, M. (2023). Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis. J Cancer Res Clin Oncol, 149(3), 1007-1017. doi:10.1007/s00432-022-03953-y
     
  149. Struck, JP, Hennig, MJP, Hupe, MC, Moharam, N, Paffenholz, P, Nestler, T, Frank, T, Worst, TS, Grabbert, M, Pohlmann, PF, Dogan, S, Hofbauer, SL, Kalogirou, C, Mattigk, A, Brandt, MP, Krabbe, LM, Reis, H, Dressler, FF, Kramer, MW, & Salem, J. (2023). Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational Survey. Urol Int, 107(1), 35-45. doi:10.1159/000518166
     
  150. Sunguc, C, Hawkins, MM, Winter, DL, Dudley, IM, Heymer, EJ, Teepen, JC, Allodji, RS, Belle, FN, Bagnasco, F, Byrne, J, Bárdi, E, Ronckers, CM, Haddy, N, Gudmundsdottir, T, Garwicz, S, Jankovic, M, van der Pal, HJH, Mazić, M, Schindera, C, Grabow, D, Maule, MM, Kaatsch, P, Kaiser, M, Fresneau, B, Michel, G, Skinner, R, Wiebe, T, Sacerdote, C, Jakab, Z, Gunnes, MW, Terenziani, M, Winther, JF, Lähteenmäki, PM, Zaletel, LZ, Kuehni, CE, Kremer, LC, Haupt, R, de Vathaire, F, Hjorth, L, & Reulen, RC. (2023). Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study. Br J Cancer, 128(1), 80-90. doi:10.1038/s41416-022-02016-w
     
  151. Talbot, T, D'Alessio, A, Pinter, M, Balcar, L, Scheiner, B, Marron, TU, Jun, T, Dharmapuri, S, Ang, C, Saeed, A, Hildebrand, H, Muzaffar, M, Fulgenzi, CAM, Amara, S, Naqash, AR, Gampa, A, Pillai, A, Wang, Y, Khan, U, Lee, PC, Huang, YH, Bengsch, B, Bettinger, D, Mohamed, YI, Kaseb, A, Pressiani, T, Personeni, N, Rimassa, L, Nishida, N, Kudo, M, Weinmann, A, Galle, PR, Muhammed, A, Cortellini, A, Vogel, A, & Pinato, DJ. (2023). Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study. Liver Int, 43(3), 695-707. doi:10.1111/liv.15502
     
  152. Taubenschmid-Stowers, J, Orthofer, M, Laemmerer, A, Krauditsch, C, Rózsová, M, Studer, C, Lötsch, D, Gojo, J, Gabler, L, Dyczynski, M, Efferth, T, Hagelkruys, A, Widhalm, G, Peyrl, A, Spiegl-Kreinecker, S, Hoepfner, D, Bian, S, Berger, W, Knoblich, JA, Elling, U, Horn, M, & Penninger, JM. (2023). A whole-genome scan for Artemisinin cytotoxicity reveals a novel therapy for human brain tumors. EMBO Mol Med, 15(3), e16959. doi:10.15252/emmm.202216959
     
  153. *Taylor, KJ, Amdal, CD, Bjordal, K, Astrup, GL, Herlofson, BB, Duprez, F, Gama, RR, Jacinto, A, Hammerlid, E, Scricciolo, M, Jansen, F, Verdonck-de Leeuw, IM, Fanetti, G, Guntinas-Lichius, O, Inhestern, J, Dragan, T, Fabian, A, Boehm, A, Wöhner, U, Kiyota, N, Krüger, M, Bonomo, P, Pinto, M, Nuyts, S, Silva, JC, Stromberger, C, Tramacere, F, Bushnak, A, Perotti, P, Plath, M, Paderno, A, Stempler, N, Kouri, M, & Singer, S. (2023). Serious Long-Term Effects of Head and Neck Cancer from the Survivors' Point of View. Healthcare (Basel), 11(6). doi:10.3390/healthcare11060906
     
  154. Thomssen, C, Vetter, M, Kantelhardt, EJ, Meisner, C, Schmidt, M, Martin, PM, Clatot, F, Augustin, D, Hanf, V, Paepke, D, Meinerz, W, Hoffmann, G, Wiest, W, Sweep, F, Schmitt, M, Jänicke, F, Loibl, S, Minckwitz, GV, & Harbeck, N. (2023). Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group. Cancers (Basel), 15(5). doi:10.3390/cancers15051580
     
  155. Tintelnot, J, Xu, Y, Lesker, TR, Schönlein, M, Konczalla, L, Giannou, AD, Pelczar, P, Kylies, D, Puelles, VG, Bielecka, AA, Peschka, M, Cortesi, F, Riecken, K, Jung, M, Amend, L, Bröring, TS, Trajkovic-Arsic, M, Siveke, JT, Renné, T, Zhang, D, Boeck, S, Strowig, T, Uzunoglu, FG, Güngör, C, Stein, A, Izbicki, JR, Bokemeyer, C, Sinn, M, Kimmelman, AC, Huber, S, & Gagliani, N. (2023). Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature, 615(7950), 168-174. doi:10.1038/s41586-023-05728-y
     
  156. Topp, M, Dlugosz-Danecka, M, Skotnicki, AB, Salogub, G, Viardot, A, Klein, AK, Hess, G, Michel, CS, Grosicki, S, Gural, A, Schwarz, SE, Pietzko, K, Gärtner, U, Strassz, A, Alland, L, & Mayer, J. (2023). Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies. Trials, 24(1), 4. doi:10.1186/s13063-022-06982-7
     
  157. van Keulen, AM, Buettner, S, Erdmann, JI, Pratschke, J, Ratti, F, Jarnagin, WR, Schnitzbauer, AA, Lang, H, Ruzzenente, A, Nadalin, S, Cescon, M, Topal, B, Olthof, PB, & Groot Koerkamp, B. (2023). Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma: does the predicted survival justify the surgical risk? Br J Surg, 110(5), 599-605. doi:10.1093/bjs/znad057
     
  158. Vedovati, MC, Giustozzi, M, Munoz, A, Bertoletti, L, Cohen, AT, Klok, FA, Connors, JM, Bauersachs, R, Brenner, B, Campanini, M, Becattini, C, & Agnelli, G. (2023). Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism. Eur J Intern Med, 112, 29-36. doi:10.1016/j.ejim.2023.02.003
     
  159. Vitale, I, Pietrocola, F, Guilbaud, E, Aaronson, SA, Abrams, JM, Adam, D, Agostini, M, Agostinis, P, Alnemri, ES, Altucci, L, Amelio, I, Andrews, DW, Aqeilan, RI, Arama, E, Baehrecke, EH, Balachandran, S, Bano, D, Barlev, NA, Bartek, J, Bazan, NG, Becker, C, Bernassola, F, Bertrand, MJM, Bianchi, ME, Blagosklonny, MV, Blander, JM, Blandino, G, Blomgren, K, Borner, C, Bortner, CD, Bove, P, Boya, P, Brenner, C, Broz, P, Brunner, T, Damgaard, RB, Calin, GA, Campanella, M, Candi, E, Carbone, M, Carmona-Gutierrez, D, Cecconi, F, Chan, FK, Chen, GQ, Chen, Q, Chen, YH, Cheng, EH, Chipuk, JE, Cidlowski, JA, Ciechanover, A, Ciliberto, G, Conrad, M, Cubillos-Ruiz, JR, Czabotar, PE, D'Angiolella, V, Daugaard, M, Dawson, TM, Dawson, VL, De Maria, R, De Strooper, B, Debatin, KM, Deberardinis, RJ, Degterev, A, Del Sal, G, Deshmukh, M, Di Virgilio, F, Diederich, M, Dixon, SJ, Dynlacht, BD, El-Deiry, WS, Elrod, JW, Engeland, K, Fimia, GM, Galassi, C, Ganini, C, Garcia-Saez, AJ, Garg, AD, Garrido, C, Gavathiotis, E, Gerlic, M, Ghosh, S, Green, DR, Greene, LA, Gronemeyer, H, Häcker, G, Hajnóczky, G, Hardwick, JM, Haupt, Y, He, S, Heery, DM, Hengartner, MO, Hetz, C, Hildeman, DA, Ichijo, H, Inoue, S, Jäättelä, M, Janic, A, Joseph, B, Jost, PJ, Kanneganti, TD, Karin, M, Kashkar, H, Kaufmann, T, Kelly, GL, Kepp, O, Kimchi, A, Kitsis, RN, Klionsky, DJ, Kluck, R, Krysko, DV, Kulms, D, Kumar, S, Lavandero, S, Lavrik, IN, Lemasters, JJ, Liccardi, G, Linkermann, A, Lipton, SA, Lockshin, RA, López-Otín, C, Luedde, T, MacFarlane, M, Madeo, F, Malorni, W, Manic, G, Mantovani, R, Marchi, S, Marine, JC, Martin, SJ, Martinou, JC, Mastroberardino, PG, Medema, JP, Mehlen, P, Meier, P, Melino, G, Melino, S, Miao, EA, Moll, UM, Muñoz-Pinedo, C, Murphy, DJ, Niklison-Chirou, MV, Novelli, F, Núñez, G, Oberst, A, Ofengeim, D, Opferman, JT, Oren, M, Pagano, M, Panaretakis, T, Pasparakis, M, Penninger, JM, Pentimalli, F, Pereira, DM, Pervaiz, S, Peter, ME, Pinton, P, Porta, G, Prehn, JHM, Puthalakath, H, Rabinovich, GA, Rajalingam, K, Ravichandran, KS, Rehm, M, Ricci, JE, Rizzuto, R, Robinson, N, Rodrigues, CMP, Rotblat, B, Rothlin, CV, Rubinsztein, DC, Rudel, T, Rufini, A, Ryan, KM, Sarosiek, KA, Sawa, A, Sayan, E, Schroder, K, Scorrano, L, Sesti, F, Shao, F, Shi, Y, Sica, GS, Silke, J, Simon, HU, Sistigu, A, Stephanou, A, Stockwell, BR, Strapazzon, F, Strasser, A, Sun, L, Sun, E, Sun, Q, Szabadkai, G, Tait, SWG, Tang, D, Tavernarakis, N, Troy, CM, Turk, B, Urbano, N, Vandenabeele, P, Vanden Berghe, T, Vander Heiden, MG, Vanderluit, JL, Verkhratsky, A, Villunger, A, von Karstedt, S, Voss, AK, Vousden, KH, Vucic, D, Vuri, D, Wagner, EF, Walczak, H, Wallach, D, Wang, R, Wang, Y, Weber, A, Wood, W, Yamazaki, T, Yang, HT, Zakeri, Z, Zawacka-Pankau, JE, Zhang, L, Zhang, H, Zhivotovsky, B, Zhou, W, Piacentini, M, Kroemer, G, & Galluzzi, L. (2023). Apoptotic cell death in disease-Current understanding of the NCCD 2023. Cell Death Differ, 30(5), 1097-1154. doi:10.1038/s41418-023-01153-w
     
  160. Vogel, MME, Wagner, A, Gempt, J, Krenzlin, H, Zeyen, T, Drexler, R, Voss, M, Nettekoven, C, Abboud, T, Mielke, D, Rohde, V, Timmer, M, Goldbrunner, R, Steinbach, JP, Dührsen, L, Westphal, M, Herrlinger, U, Ringel, F, Meyer, B, & Combs, SE. (2023). Impact of the SARS-CoV-2 pandemic on the survival of patients with high-grade glioma and best practice recommendations. Sci Rep, 13(1), 2766. doi:10.1038/s41598-023-29790-8
     
  161. Wu, YL, van Hyfte, G, Özbek, U, Reincke, M, Gampa, A, Mohamed, YI, Nishida, N, Wietharn, B, Amara, S, Lee, PC, Scheiner, B, Balcar, L, Pinter, M, Vogel, A, Weinmann, A, Saeed, A, Pillai, A, Rimassa, L, Naqash, AR, Muzaffar, M, Huang, YH, Kaseb, AO, Kudo, M, Pinato, DJ, & Ang, C. (2023). Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors. Front Oncol, 13, 1128569. doi:10.3389/fonc.2023.1128569
     
  162. *Youmbi, LM, Makong, YSD, Mbaveng, AT, Tankeo, SB, Fotso, GW, Ndjakou, BL, Wansi, JD, Beng, VP, Sewald, N, Ngadjui, BT, Efferth, T, & Kuete, V. (2023). Cytotoxicity of the methanol extracts and compounds of Brucea antidysenterica (Simaroubaceae) towards multifactorial drug-resistant human cancer cell lines. BMC Complement Med Ther, 23(1), 48. doi:10.1186/s12906-023-03877-1
     
  163. *Zahnreich, S, Yusifli, K, Poplawski, A, Eckhard, LS, Mirsch, J, Hankeln, T, Galetzka, D, Marron, M, Scholz-Kreisel, P, Spix, C, & Schmidberger, H. (2023). Replication stress drives chromosomal instability in fibroblasts of childhood cancer survivors with second primary neoplasms. DNA Repair (Amst), 122, 103435. doi:10.1016/j.dnarep.2022.103435
     
  164. *Ziegler, N, Cortés-López, M, Alt, F, Sprang, M, Ustjanzew, A, Lehmann, N, El Malki, K, Wingerter, A, Russo, A, Beck, O, Attig, S, Roth, L, König, J, Paret, C, & Faber, J. (2023). Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL. Oncoimmunology, 12(1), 2184143. doi:10.1080/2162402x.2023.2184143
     
  165. Zolotovskaia, MA, Modestov, AA, Suntsova, MV, Rachkova, AA, Koroleva, EV, Poddubskaya, EV, Sekacheva, MI, Tkachev, VS, Garazha, AV, Glusker, AA, Seryakov, AP, Vladimirova, US, Rumiantsev, PO, Moisseev, AA, Zharkov, DO, Kuzmin, DV, Zhao, X, Prassolov, VS, Shegay, PV, Li, X, Steinbichler, TB, Kim, E, Sorokin, MI, Wang, Y, & Buzdin, AA. (2023). Pan-cancer antagonistic inhibition pattern of ATM-driven G2/M checkpoint pathway vs other DNA repair pathways. DNA Repair (Amst), 123, 103448. doi:10.1016/j.dnarep.2023.103448
     
  166. *Züger, A, Fischbeck, S, Weber, M, & Mai, S. (2023). Revision of the Advanced Cancer Patients' Distress Scale (ACPDS): a mixed-methods study among palliative patients and healthcare professionals in Germany. BMJ Open, 13(4), e066998. doi:10.1136/bmjopen-2022-066998